Correspondence | Published:

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

Nature Medicine volume 13, pages 1314 (2007) | Download Citation


  • A Corrigendum to this article was published on 01 February 2007

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. Nat. Med. 12, 908–916 (2006).

Download references

Author information


  1. Department of Internal Medicine, Section of Hematology, University of Milano, Bicocca and San Gerardo Hospital, Via Cadore 48, 20052 Monza, Italy

    • Carlo Gambacorti
    • , Lucia Tornaghi
    • , Anna Franceschino
    • , Rocco Piazza
    • , Gianmarco Corneo
    •  & Enrico Pogliani
  2. Jewish General Hospital and McGill University, 3755 Cote Sainte Catherine, Montreal H3T 1E2, Canada.

    • Carlo Gambacorti


  1. Search for Carlo Gambacorti in:

  2. Search for Lucia Tornaghi in:

  3. Search for Anna Franceschino in:

  4. Search for Rocco Piazza in:

  5. Search for Gianmarco Corneo in:

  6. Search for Enrico Pogliani in:

Competing interests

The authors declare no competing financial interests.

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing